Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01852344 · ClinicalTrials.gov registry record · NA

Behavioral Differences in Effortful Control

A NA study of Healthy, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
108
Enrollment target
1
Study location

NCT01852344: Completed NA study of Healthy, sponsored by University of Michigan.

NCT01852344 is a NA study of Healthy that has completed, run by University of Michigan. The registered enrollment target is 108 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01852344, a NA study of Healthy, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
108 participants
Enrollment target
1
Study location

Study Summary

Effortful control refers to the mental processes that help a person to regulate his or her own attention, thoughts, and emotions. This study will examine behavioral differences in healthy individuals when performing a task that induces fatigue. The purpose of this study is to examine the effects of methylphenidate on the cognitive functions in healthy individuals when performing fatiguing cognitive tasks.

Primary Outcome

Reaction time on the Multi-Source Interference Task is measured in milliseconds. Participants were given 200 trials and their mean reaction time was calculated.

Conditions Studied

Interventions

  • DRUG Placebo
  • DRUG Methylphenidate
  • BEHAVIORAL Easy Behavioral Task
  • BEHAVIORAL Hard Behavioral Task

Study Locations (1)

Michigan

  • Rachel Upjohn Building, East Medical Campus - Ann Arbor

Trial Details

FieldValue
Enrollment Target 108 participants
Start Date 2012-06
Est. Completion 2017-04-24
Phase NA
University of Michigan

1,327 total trials

What the finished NCT01852344 record still lists

NCT01852344 is an interventional study that assigns participants to a tested intervention. The registered 108 participants enrollment target is mid-sized for trials with a published cap, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (83% lower).

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 4 interventions - of which Placebo is the first listed.

NCT01852344 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT01852344 about?

NCT01852344 is a clinical study titled "Behavioral Differences in Effortful Control". Effortful control refers to the mental processes that help a person to regulate his or her own attention, thoughts, and emotions. This study will examine behavioral differences in healthy individuals when performing a task that induces fatigue. The purpose of this study is to examine the effects of...

What is the current status of trial NCT01852344?

This trial is currently completed. It is a NA study. The enrollment target is 108 participants. The study started on 2012-06. Estimated completion is 2017-04-24.

What conditions does trial NCT01852344 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT01852344?

The interventions under investigation include: Placebo (DRUG), Methylphenidate (DRUG), Easy Behavioral Task (BEHAVIORAL), Hard Behavioral Task (BEHAVIORAL).

Who is sponsoring clinical trial NCT01852344?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01852344 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01852344's enrollment target sits among peer trials

108 204th of 1090 higher than 884 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02703207 · 108 participants · NA

    Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD

  • NCT02744677 · 108 participants · NA

    COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction

  • NCT02781883 · 108 participants · Phase 2

    Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML

  • NCT03848663 · 108 participants · NA

    Visual Remapping to Aid Reading With Field Loss

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01852344, the US trial registry maintained by the National Library of Medicine. NCT01852344 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.